Quantitative characterization of mitosis-blocked tetraploid cells using high content analysis

Assay and Drug Development Technologies

Volumn 4, Issue 4, 2006, Pages 421-442

  Grove, Linnette E ^a   Ghosh, Richik N ^a,b  

^a Cellomics Inc   (United States)

^b Pierce Biotechnology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; F ACTIN; FLUORESCENT DYE; HISTONE H3; NOCODAZOLE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUBULIN;

ANTIBODY LABELING; ARTICLE; AUTOMATION; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONTENT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA CONTENT; DRUG SCREENING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MITOSIS INDEX; MITOSIS INHIBITION; MITOSIS RATE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; TETRAPLOIDY; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HISTONES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MITOSIS; MITOTIC INDEX; NOCODAZOLE; PHOSPHORYLATION; POLYPLOIDY; RETINOBLASTOMA PROTEIN; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33751232619     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.421     Document Type: Article

References (50)

1. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828.
2. Nurse P: Checkpoint pathways come of age. Cell 1997;9: 865-867.
3. Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677.
4. Nurse P: A long twentieth century of the cell cycle and beyond. Cell 2000;100:71-78.
5. Malumbres M, Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001;1:222-231.
6. Kung AL, Sherwood SW, Schimke RT: Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc Natl Acad Sci U S A 1990;87: 9553-9557.
7. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 1995;267:1353-1356.
8. Minn AJ, Boise LH, Thompson CB: Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 1996;10:2621-2631.
9. Lanni JS, Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998;18:1055-1064.
10. Khan SH, Wahl GM: p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 1998;58:396-401.
11. Casenghi M, Mangiacasale R, Tuynder M, Caillet-Fauquet P, Elhajouji A, Lavia P, Mousset S, Kirsch-Volders M, Cundari E: p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. Exp Cell Res 1999;250:339-350.
12. Meek DW: The role of p53 in the response to mitotic spindle damage. Pathol Biol 2000;48:246-254.
13. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL: Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001;12: 1315-1328.
14. Ciciarello M, Mangiacasale R, Casenghi M, Zaira Limongi M, D'Angelo M, Soddu S, Lavia P, Cundari E: p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle. J Biol Chem 2001;276:19205-19213.
15. Andreassen PR, Lacroix FB, Lohez OD, Margolis RL: Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 2001;61:7660-7668.
16. Abraham VC, Taylor DL, Haskins JR: High content screening applied to large-scale cell biology. Trends Biotechnol 2004;22:15-22.
17. Giuliano KA, Haskins JR, Taylor DL: Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-577.
18. Ghosh RN, Lapets O, Haskins JR: Characteristics and value of directed algorithm in HCS. In: High Content Screening. A Powerful Approach to Systems Cell Biology and Drug Discovery, in press. Taylor DL, Giuliano KA, Haskins JR (eds.), Humana Press, Totowa, NJ, 2006.
19. Conway BR, Minor LK, Xu JZ, D'Andrea MR, Ghosh RN, Demarest KT: Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate. J Cell Physiol 2001;189:341-355.
20. Gasparri F, Mariani M, Sola F, Galvani A: Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader. J Biomol Screen 2004;9:232-243.
21. Ghosh RN, Chen YT, DeBiasio R, DeBiasio RL, Conway BR, Minor LK, Demarest KT: Cell-based, high-content screen for receptor internalization, recycling and intracellular trafficking. Biotechniques 2000;29:170-175.
22. Ghosh RN, Grove L, Lapets O: A quantitative high content screening assay for retinoblastoma protein phosphorylation and the cell cycle. Presented at the Ninth Annual Meeting of the Society for Biomolecular Screening, Portland, OR, 2003.
23. Ghosh RN, DeBiasio R, Hudson CC, Ramer ET, Cowan CL, Oakley RH: Quantitative cell-based high content screening assay for vasopressin receptor agonists using transfluor technology. J Biomol Screen 2005; 10:476-484.
24. Giuliano KA, Chen YT, Taylor DL: High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs. J Biomol Screen 2004; 9:557-568.
25. Lovborg H, Nygren P, Larsson R: Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828. Mol Cancer Ther 2004;3:521-526.
26. Mastyugin V, McWhinnie E, Labow M, Buxton F: A quantitative high-throughput endothelial cell migration assay. J Biomol Screen 2004;9:712-718.
27. Richards GR, Millard RM, Leveridge M, Kerby J, Simpson PB: Quantitative assays of chemotaxis and chemokinesis for human neural cells. Assay Drug Dev Technol 2004;2:465-472.
28. Vakkila J, DeMarco RA, Lotze MT: Imaging analysis of STAT1 and NF-kappaB translocation in dendritic cells at the single cell level. J Immunol Methods 2004;294:123-134.
29. Vogt A, Kalb EN, Lazo JS: A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity. Oncol Res 2004;14:305-314.
30. Abraham VC, Samso B, Lapets O, Haskins JR: Automated classification of individual cellular responses across multiple targets. Preclinica 2004;2:349-355.
31. Ghosh RN, Grove L, Lapets O: A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. Assay Drug Dev Technol 2004;2:473-481.
32. Edwards BS, Oprea T, Prossnitz ER, Sklar LA: Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 2004;8:392-398.
33. Darzynkiewicz Z, Bedner E, Smolewski P: Flow cytometry in analysis of cell cycle and apoptosis. Semin Hematol 2001;38:179-193.
34. Nunez R: DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol 2001;3:67-70.
35. Ghosh RN, Grove L: Decoupling retinoblastoma protein dephosphorylation from mitosis. Mol Biol Cell 2003;14 (Suppl):2306.
36. Castleman KR: Digital Image Processing. Prentice Hall, Upper Saddle River, NJ, 1996.
37. Vasquez RJ, Howell B, Yvon AM, Wadsworth P, Cassimeris L: Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro. Mol Biol Cell 1997;8:973-985.
38. Jordan MA, Thrower D, Wilson L: Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci 1992;102:401-416.
39. Mittnacht S: Control of pRB phosphorylation. Curr Opin Genet Dev 1998;8:21-27.
40. Kaelin WG Jr: Functions of the retinoblastoma, protein. Bioessays 1999;21:950-958.
41. Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T, Inagaki M: Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 1999;274:25543-25549.
42. Rieder CL, Khodjakov A: Mitosis through the microscope: advances in seeing inside live dividing cells. Science 2003;300:91-96.
43. Ghosh RN, Grove L, Dorris D, Jarvis R, Brown D, Haskins JR: Quantitative high content screening evaluation of a siRNA kinase library on downstream phenotypic changes in cell morphology and cytoskeletal rearrangement. Presented at the Tenth Annual Meeting of the Society for Biomolecular Screening, Orlando, FL, 2004.
44. Grove L, Lapets O, Ramer E, Ghosh RN: Automated, quantitative analysis of cytoskeletal rearrangement over multiple spatial dimensions using high content screening. Presented at the Tenth Annual Meeting of the Society for Biomolecular Screening, Orlando, FL, 2004.
45. Giuliano KA: High-content profiling of drug-drug interactions: cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J Biomol Screen 2003;8:125-135.
46. Minguez JM, Giuliano KA, Balachandran R, Madiraju C, Curran DP, Day BW: Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)-discodermolide. Mol Cancer Ther 2002;1:1305-1313.
47. Minguez JM, Kim SY, Giuliano KA, Balachandran R, Madiraju C, Day BW, Curran DP: Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide. Bioorg Med Chem 2003;11:3335-3357.
48. Vogt A, Adachi T, Ducruet AP, Chesebrough J, Nemoto K, Carr BI, Lazo JS: Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual-specificity phosphatases. J Biol Chem 2001;276:20544-20550.
49. Vogt A, Cooley KA, Brisson M, Tarpley MG, Wipf P, Lazo JS: Cell-active dual specificity phosphatase inhibitors identified by high-content screening. Chem Biol 2003;10:733-742.
50. Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, Lazo JS: The benzôphenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 2005;280: 19078-19086.